http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6017733-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_182e5bcb9e697c8fe00976d852dd48c8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-20
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
filingDate 1998-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd10d7a87a2de2adbc774aa342db9aa0
publicationDate 2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6017733-A
titleOfInvention Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
abstract Disclosed herein are fully impaired consensus Kozak sequences which are most typically used with dominant selectable markers of transcriptional cassettes which are a part of an expression vector, These vectors are most typically utilized in the expression of proteins in mammalian expression systems. As defined, disclosed and claimed herein, a "fully impaired consensus Kozak" comprises the following sequence: - - -3 +1 - Pyxx ATG Pyxx - where: "x" is a nucleotide selected from the group consisting of adenine (A), quanine (G), cytosine (C) or thymine (T)/uracil (U); "Py" is a pyrimidine nucleotide, ie C or T/U; "ATG" is a codon encoding for the amino acid methionine, the so-called "start" codon; and -3 and +1 are directional reference points vis-a-vis ATG, ie -3 is meant to indicate three nucleotides upstream of ATG and +1 is meant to indicate one nucleotide downstream of ATG. Dominant selectable markers further comprising artificial intronic insertion regions are further disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011008337-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011008336-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9683047-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3747464-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010075249-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9993550-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7604989-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007071674-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2022799-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3095463-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011008250-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004258616-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7820161-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10344299-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002058029-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005153394-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8545843-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7674618-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011100403-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010158903-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9994642-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011008338-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003064510-A1
priorityDate 1992-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0682040-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0451216-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5366546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23636559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136099267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20054942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136380179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136134158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226452379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226452378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106

Total number of triples: 77.